You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 70 No. 4, April 1955 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (16)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Prostatic Cancer X

Comparison of Open and "Punch" Biopsy Techniques

PERRY B. HUDSON, M.D.; ALEX L. FINKLE, M.D.; HAROLD M. JOST, M.D.; ARISTIDES TRIFILIO, M.D.; ARTHUR PURDY STOUT, M.D.

AMA Arch Surg. 1955;70(4):508-512.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

With the progressive increase in life span of the average American man, there has been a concomitant increase in the clinical incidence of and the death rate from adenocarcinoma of the prostate gland.1 This increasing death rate from prostatic cancer seems surprising when one considers that a curative operation for early prostatic cancer was described almost 50 years ago.2 Moreover, the cancer-free survival of properly selected prostatic cancer patients subjected to radical perineal prostatectomy compares favorably with curative surgery for adenocarcinoma arising in other parts of the body.3 The increasing prostatic cancer death rate must then be attributed to the well known fact that even today approximately 95% of all prostatic cancers are first diagnosed clinically in metastatic phase.4 Although promising palliative methods, notably castration and the administration of estrogenic substances, have altered the prognosis for the metastatically involved patient somewhat, such an individual lives only . . . [Full Text PDF of this Article]


Author Affiliations

New York

From the Departments of Urology and Pathology, Francis Delafield Hospital, and the Institute of Cancer Research, Columbia University College of Physicians and Surgeons.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1955 American Medical Association. All Rights Reserved.